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Abstract
Background: Pseudorabies virus (PRV), a neurotropic herpesvirus of pigs, serves as an excellent
model system with which to investigate the herpesvirus life cycle both in cultured cells and in vivo.
Real-time RT-PCR is a very sensitive, accurate and reproducible technique that can be used to
detect very small amounts of RNA molecules, and it can therefore be applied for analysis of the
expression of herpesvirus genes from the very early period of infection.
Results: In this study, we have developed and applied a quantitative reverse transcriptase-based
real-time PCR technique in order to profile transcription from the whole genome of PRV after lytic
infection in porcine kidney cells. We calculated the relative expression ratios in a novel way, which
allowed us to compare different PRV genes with respect to their expression dynamics, and to divide
the PRV genes into distinct kinetic classes. This is the first publication on the whole-genome
analysis of the gene expression of an alpha-herpesvirus by qRT2-PCR. We additionally established
the kinetic properties of uncharacterized PRV genes and revised or confirmed data on PRV genes
earlier examined by traditional methods such as Northern blot analysis. Our investigations revealed
that genes with the same expression properties form clusters on the PRV genome: nested
overlapping genes belong in the same kinetic class, while most convergent genes belong in different
kinetic classes. Further, we detected inverse relationships as concerns the expressions of EP0 and
IE180 mRNAs and their antisense partners.
Conclusion: Most (if not all) PRV genes begin to be expressed from the onset of viral expression.
No sharp boundary was found between the groups of early and late genes classified on the basis of
their requirement for viral DNA synthesis. The expressions of the PRV genes were analyzed,
categorized and compared by qRT2-PCR assay, with the average of the minimum cycle threshold
usedasacontrolforthecalculationofaparticularRvalue.Inprinciple,thisnewcalculationtechnique
is applicable for the analysis of gene expression in all temporally changing genetic systems.
Background
The pseudorabies virus (PRV; also called Aujeszky's
disease virus or suid herpesvirus type 1) is a member
of the alpha-herpesviruses and an important pathogen of
pigs, causing Aujeszky's disease [1]. The PRV is a valuable
model organism in herpesvirus research [2] and also a
powerful tool in neuroscience, employed to map neural
circuits [[3-5], and [6]] and gene delivery [7]. The PRV
life cycle is primarily controlled at the level of transcrip-
tion. The genes of a-herpesviruses are divided into three
Page 1 of 22
(page number not for citation purposes)
BioMed  Central
Open Accessmajor temporal classes (immediate-early, IE or a;e a r l y ,E
or b,a n dl a t e ,Lo rg), which are regulated in a
coordinated, cascade-like fashion [[8] and [9]]. First,
the IE genes are expressed, independently of de novo
protein synthesis from the virus. The products of these
genes are transcription factors and other regulatory
proteins. PRV IE180 protein [homologous to herpes
simplex virus (HSV) ICP4 protein] is the major regulator
of the transcription of the E genes, which in turn are
mainly involved in replication of the viral DNA. Blockers
of DNA synthesis inhibit the E gene expression to a
much lesser extent than the L gene expression. On a finer
scale, the E genes can be subdivided into b1( E )a n db2
(E/L) genes. Finally, the L genes are transcribed,
encoding mainly structural proteins involved in virion
assembly. The expression of the L genes is partially (g1,
leaky L genes) or completely (g2, true L genes)
dependent on the viral DNA replication. HSV encodes
5 IE genes: icp0, icp4, icp22, icp27 and icp47. By contrast,
PRV has been reported to express ep0 (homologous to
icp0 of HSV; [10] and ul54 (the homolog of icp27 of HSV;
[11]) proteins in the E kinetics, and it lacks the icp47
gene. The ie180 gene of PRV has been shown to be a true
IE gene in various experimental systems [[12] and [13]];
however, there is no consensus as to whether the US1
protein (Rsp40; homologous to HSV ICP22) is expressed
in the IE [14] or the E kinetics [15]. Herpesviruses are
capable of two types of infections: lytic (or productive)
and latent [2]. In the lytic pathway, the entire transcrip-
tion machinery of the herpesvirus is initiated, and the
progress of infection eventually leads to the production
of new virions and the lysis of infected cells. In contrast,
in latency, only a limited segment (LAT region) of the
herpesvirus genome is transcriptionally active, no new
virus particles are produced and the cells survive the
infection. A characteristic feature of the organization of
t h eh e r p e s v i r u sg e n o m ei st h ep r e s e n c eo fn e s t e dg e n e s
producing 3'-coterminal transcripts. The read-through of
overlapping genes is regulated by the ICP27 protein,
which helps in the recognition of the internal polyA
signals, resulting in differential transcript lengths [16].
The gene expression of a-herpesviruses, such as HSV
types 1 and 2, Varicella-zoster virus, bovine herpesvirus
type 1 and PRV has been investigated earlier by
traditional methods including Northern blot analysis,
ribonuclease protection assay, and end-point RT-PCR
analysis. However, each of these techniques is associated
with a number of disadvantages. For example, Northern
blot analysis is labor-intensive, allows only semiquanti-
tative determination of the mRNA level and is unsuitable
for multiple mRNA analysis. Moreover, hybridization-
based membrane arrays profile changes in a nonlinear
fashion, tending to overemphasize large alterations, and
they are insensitive to smaller variations. Ribonuclease
protection assay-based methods require the use of
polyacrylamide gel electrophoresis and typically utilize
radioactively labeled probes. The limitations of endpoint
PCR technique are the time-consuming procedure, the
poor precision and the variable endpoints between
samples. Over the past few years, microarray techniques
have revolutionized practically all disciplines of mole-
cular biology, including herpesvirus research. As com-
pared with traditional methods, microarray analysis is
superior in that it is applicable for the simultaneous
analysis of a large number of genes, and even whole
genomes. The disadvantage of DNA chip technology is
associated with the uncertain quality control: it is
impossible to assess the identity of DNA immobilized
on any microarray. Further, there are many artifacts
associated with image and data analysis. Real-time RT-
PCR is an alternative to microarray techniques for the
analysis of transcription from multiple genes. The main
advantage of real-time PCR is that it is more sensitive to
low-fold changes than other high-throughput assays. In
addition, the real-time PCR technique provides a
reproducible quantitation of DNA copies, and has a
large dynamic range, and various controls can be
included to ensure accuracy, such as a loading control
to verify equal cDNA loading, a no-primer control to
prove a measure of non-amplification-related back-
ground, a no-template control to screen for contamina-
tion of reagents or false amplification, and a no-RT
control with confirm the absence of DNA contamina-
tion. In contrast to microarray techniques, in real-time
PCR the parameters for each gene can be optimized
individually. Moreover, the identity of PCR products can
be confirmed through melting curve analysis, restriction
endonuclease analysis, or DNA sequencing. In fact, real-
time PCR is often used to verify gene expression data
obtained by microarrays. Nevertheless, considerable
pitfalls may be associated with this technique. The
major limitations of real-time RT-PCR relative to
microarray techniques are the higher cost and labor
intensiveness for a large number of samples. Another
disadvantage of real-time PCR as compared with blotting
techniques is that only the accumulation, but not the
size of the transcripts can be monitored. Microarray
techniques have recently been applied to investigate
herpesvirus gene expression [[17-19] and [20]]; to
analyze the effects of the deletion of particular viral
genes or of the specific experimental conditions on
whole-genome viral gene expression [[21,22], and [23]];
and to analyze the impact of virus infection on the
expression of cellular genes [[24-26] and [27]]. The
expression of PRV genes has been studied by traditional
methods, but many its genes have not yet been
characterized at all. Flori and co-workers [27] investi-
gated the dialog between PRV and epithelial cells, but
obtained poor resolution for viral transcripts that did not
provide conclusive data on the temporal expression of
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frequently utilized in herpesvirus research for global
gene expression analysis. With this technique Oster and
Höllsberg [28] carried out a kinetic analysis of 35 genes
of human herpesvirus 6B, a b-herpesvirus, and Dittmer
and colleagues [29] performed a whole-genome profil-
ing of the rhesus monkey rhadinovirus, a g-herpesvirus.
As far as we are aware, no genome-wide expression data
obtained by qRT2-PCR have been published so far on a-
herpesviruses. In the present study, we describe the
development and utilization of a real-time RT-PCR assay
for the global analysis of PRV gene expression. We
applied a novel method that allows the kinetic char-
acterization of individual PRV genes, and also the
comparison of the expression dynamics of different
viral genes. Expression profiles were constructed on the
basis of relative expression ratios (Rs) calculated as
described in the Materials section. This method is
applicable for the analysis of gene expression in any
genetic system that progressively changes in time.
Results
Experimental design
For each gene, a minimum of 3 independent replicates
were carried out for statistical confidence, and the
median of these values along with the standard error
was calculated. In these experiments, porcine kidney
(PK)-15 epithelial cells were infected with PRV with a
low multiplicity of infection [MOI; 0.1 plaque-forming
units (pfu)/cell]. The reason for this was that our
preliminary experiments indicated that infecting cells
with a low dose of the virus produced a much better
resolution of the cycle threshold (Ct) values for PRV
genes at different time points than infecting with a
higher MOI (data not shown). However, the use of a low
MOI led to a larger proportion of the cells remaining
uninfected; accordingly, in order to avoid the initiation
of a new infection cycle we chose a relatively short
maximal incubation period. Initially, we attempted an 8-
h investigation period, but observed a second infection
wave of the virus (data not shown), and therefore we
restricted our analysis to 6 h post-infection (pi). The
transcription of PRV genes was monitored at 5 time
points: 0, 1, 2, 4 and 6 h. Prior to PRV infection, cells
were either untreated or treated with cycloheximide
(CHX), a protein synthesis blocker, or phosphonoacetic
acid (PAA), an inhibitor of DNA synthesis. We used
strand-specific primers for the reverse transcription, one
of the reasons for this being that we intended to exclude
the distorting effects of potential overlapping antisense
RNAs transcribed from the antiparallel DNA strands,
which cannot be distinguished by oligo-dT- or random
priming-based RT (this issue will be described else-
where). Another reason was that it produced a much
higher amount of specific cDNAs than oligo-dT priming
(data not shown), which was especially important under
our experimental conditions with a low MOI. We
utilized the mathematical model for relative quantifica-
tion described by Soong et al. [30]; however, we
calculated the R values in a different way: we used the
average of the maximal E
Ct-sample values for each gene as
a control, which was normalized with the average of the
corresponding 28S values (E
Ct-reference). Thus, in our
calculation, a particular R value indicates the ratio of the
mRNA level of a gene at a given time point to the
maximal RNA level of this gene (maximal gene expres-
sion occurred at 6 h pi for all genes except us3 and llt2,
w h i c hp e a k e da t4ha n da t2hp i ,r e s p e c t i v e l y ) .T h e
relative amounts of the transcripts of different genes
cannot be compared because the primer efficiencies may
vary both in RT and in PCR. Even so, use of the maximal
expression as the control value allows a comparison of
the expression dynamics of viral genes both at individual
time points and across the entire infection period. The
specificity of the PCR products was confirmed by quality
control experiments, including Tm analysis and PAGE
(formation of a single product with the appropriate
molecular weight was accepted); if some doubts
remained, the amplification products were subjected to
DNA sequencing or restriction endonuclease analysis
using amplicons containing recognition sites for a
particular restriction endonuclease [see Additional file
1]. The accuracy of sampling and qRT2-PCR analysis
were ensured by using loading controls, as well as no-RT,
no-primer and no-template controls (Figure 1).
Reproducibility of the internal control
A major concern regarding the choice of internal
reference gene control in viral gene expression studies
is the constancy of the reference gene products through-
out the entire examination period. We tested whether the
28S ribosomal RNA of the pig fulfilled this requirement,
and found that this gene was suitable as reference gene
for the study of PRV infection, at least in our 6-h
examination period. The 28S rRNA values were highly
reproducible: the mean value ± SD of all measurements
the experiments was 8.03 ± 0.61 cycles throughout
(Figure 2).
Classification of PRV genes in terms of dependence on de
novo protein synthesis and DNA replication
Traditionally, lytic herpesvirus genes are classified into
distinct kinetic groups on the basis of the effects of
protein and DNA synthesis inhibition on the gene
expression. In general, inhibitory drugs are applied to
infected cells for a prolonged incubation period (24, 48
or 72 h; [[31,32] and [33]]. Instead, similarly to Stingley
et al [18], we used shorter incubation periods (2, 4 and 6
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inhibitory effects of these drugs by calculating the R
value ratios for the treated and untreated samples.
CHX analysis
To test the requirement of de novo protein synthesis for
PRV mRNA production, PK-15 cells were untreated or
treated with 100 μg/ml CHX prior to the infection of
cells with the virus. At the indicated time points, RNA
w a si s o l a t e da n dc o n v e r t e dt oc D N A ,w h i c hw a s
subsequently analyzed by qRT2-PCR. The degree of
inhibition [1-Ri-CHX) × 100] was found to range between
97.3 and 100% for all but one protein encoding PRV
gene (the ie180 gene) and two antisense transcripts [the
long-latency transcript-1 (llt1), antiparallel to ep0, and
the long-latency transcript-2 (llt2), antiparallel to ie180).
IE180 mRNA displayed a significantly increased level of
expression in the CHX-treated samples at the analyzed 3
time points: 2.27-fold at 2 h; 5.55-fold at 4 h; 1.4-fold at
6 h pi (Figure 3). We explain this phenomenon in that
the IE180 proteins exert an inhibitory effect on their own
synthesis (upon the binding of their own promoters; [34]),
which is resolved by CHX blocking protein synthesis
from the IE180 mRNAs. The other exception for the
negative CHX effect is llt2: a 1.72-fold increase at 2 h and
a 3.983-fold increase at 4 h. Interestingly, at 6 h pi llt2 is
significantly repressed by CHX. The repression of llt1
expression at 2 h pi is relatively low (Ri-CHX-2h = 0.281),
Figure 1
Controls for qRT
2-PCR. Polyacrylamide gel
electrophoresis of the products from 30 cycles of real-time
PCR on cDNA derived from PK-15 cells infected by the PRV
f o r1 ,2 ,4o r6ho rf r o mc e l l si n f e c t e db yt h ev i r u sf o r4o r6
h and treated with CHX or PAA. A no-template control was
used for each primer pair, consisting of water, to test for
false-positive results, and no-RT control was used to ensure
the absence of DNA contamination. The GeneRuler™ Low
Range DNA Ladder (Fermentas) is shown at the left side of
the photo. The cDNAs of ie180 gene (a) and ul30 gene (b)
were used for the presentation.
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Figure 2
Reproducibility of the reference control.T h e
constancy of the 28S rRNA level (shown by the similar Ct
values) throughout the 6-h infection period indicates that
this gene serves as an appropriate reference control.
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Figure 3
Effects of the CHX on the expression of ie180, llt1, llt2
and ep0 genes. This Figure shows the dependence of the
PRV gene expression on de novo protein synthesis on two
genes (ie180 and ep0) and two antisense transcripts (llt1 and
llt2) overlapping these genes. PK-15 cells infected with PRV
were incubated in the presence or absence of CHX for 2, 4
or 6 h. The CHX-mediated inhibition of viral gene
expression (Ri-CHX) was calculated as follows: Ri-CHX =
RCHX/RUT,w h e r eR CHXis the R value of the CHX-treated
samples; and RUTis the R value of the untreated samples.
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CHX at 4 and 6 h pi. Overall, our CHX analysis indicated
t h a tt h eo n l yt r u eI Ep r o t e i n - e n c o d i n gg e n eo fP R Vi s
ie180. While the icp27 and icp0 genes in the HSV are IE
genes, their PRV homologs ul54 [11] and ep0 [10] genes
were earlier described as E genes, which was confirmed
by our CHX analysis. The icp22 gene of HSV is expressed
with IE kinetics; our analysis revealed that its homo-
logous counterpart, the us1 gene of PRV, is significantly
blocked by CHX, and hence it is not an IE gene. As a
result of CHX treatment, LLT2 exhibits elevated levels at
2 and 4 h pi, which indicates that IE180 transcription
factor exerts a negative effect on its expression. Thus,
LLT2 appears to be an IE transcript. However, llt2
displays fairly low relative expression at 1 h pi [see
Additional file 2], and therefore it cannot be regarded as
an IE gene beyond doubt.
PAA analysis
For examination of the dependence of the PRV genes on
DNA replication, PK-15 cells were infected with the virus
in the absence or presence of 400 μg/ml PAA, an
inhibitor of DNA polymerase. It was expected that PAA
would exert a more drastic effect on the L genes because
the expressions of these genes are highly dependent on
DNA replication. However, PAA must affect the E gene
expression, too. The reason for this is that the gene
expression is dependent not only on the promoter
activity, but also on the copy numbers of the genes,
which are higher after DNA replication than in the initial
phase of infection when the PRV DNA is represented in a
single copy in a cell (at least in our system). The
inhibitory effect of PAA on gene expression was
calculated by using the ratio of the R values for the
PAA-treated/untreated samples at 6 h pi (Ri-PAA =R 6h-
PAA/R6h-UT) :al o wr a t i oi n d i c a t e sas t r o n gi n h i b i t o r y
effect and vice versa. The PRV genes were ranked from
the least inhibited (highest Ri-PAA) to the most inhibited
(lowest Ri-PAA). We expected that such a ranking of the
PRV genes on the basis of the inhibitory effect would
provide natural clusters of E and L genes. Indeed, the
results obtained conformed fairly well to the data
published earlier on HSV and PRV genes, though there
is a certain degree of disagreement between the data
published by the different authors on the HSV genes, and
only incomplete expression data are available for the
PRV genes. Moreover, in many cases a PRV gene is
characterized without comparative analysis, e.g. "it
appears 3 h pi". For comparison of the HSV and PRV
genes, we used five main sources for the HSV data:
microarray data published by Wagner [35,36]; various
expression data compiled by Roizman [37,38]; and the
data collected by Mettenleiter [39]. For the PRV genes,
we used the data compiled by Mettenleiter [39]. We
classified the analyzed but uncategorized PRV genes via
the following principles: if the mRNA was detected
b e t w e e n1a n d2hp i , ,b e t w e e n3a n d4hp i ,o r5hp i ,
the particular gene was classified as E, E/L or L,
respectively. In the upper part of the ranking list
(Table 1, Figure 4), [see Additional file 3], we mostly
find typical E genes, with typical L genes in the bottom
part of the list. However, we could not draw a clear-cut
line between the E and L genes; instead, we put the 15
genes with intermediate values in the E/L group. The
precise locations of borderlines between kinetic classes
were drawn arbitrarily, because we found smooth
transitions between the Ri-PAA values. We chose a typical
Eg e n e( u l 5 2 )o ft h eH S Va st h el a s tm e m b e ro ft h eE
group, and a typical L gene (ul32) of the HSV as the first
member of the L group. The 3 protein-encoding genes
with the highest Ri-PAA values were ul30 (0.851), ul23
(0.752) and us3 (0.739). These high Ri-PAA values
indicate that PAA does not exert a significant cytotoxic
effect on the gene expression apart from blocking DNA
replication. The 2 LLT transcripts display a surprising
response to PAA treatment: the level of LLT1 increases to
2.94-fold at 4 h, and drops to 0.007-fold at 6 h pi relative
to the untreated sample; while the level of LLT2 increases
markedly close to 40-fold at 4 h, and 3-fold at 6 h pi
(this phenomenon will be discussed later). The genes
with the lowest Ri-PAA values are all but one (us1: 0.042)
L genes in the HSV: ul16 (0.000), ul1 (0.041) and ul38
(0.042). The strong inhibitory effect of PAA on the us1
expression is surprising because it is an IE gene in the
HSV. The ie180 gene expression is also significantly
inhibited by PAA (0.211); however, we found that ie180
and to a certain extent us1 were expressed in an
"irregular" manner in other analyses, too (see later).
ul11 and ul21, which are L genes in HSV, do not appear
to belong in the E kinetic class. Both genes were
characterized as L genes in the PRV by De Wind et al.
[59] using Northern blot analysis. Furthermore, ul13 is
an L gene in the HSV, but its transcripts were detected at
2hp ii nt h eP R V .T h eu l 2a n du l 5g e n e sa r eEg e n e si n
the HSV, but were characterized as E/l and L genes,
r e s p e c t i v e l y ,i nt h eP R Vb yD e a na n dC h e u n g[ 5 5 , 6 0 ] ,
respectively, which is in agreement with our results. We
classified the kinetically still uncharacterized PRV genes
a sf o l l o w s ;Eg e n e s :u s 3 ,u l 2 9a n du l 3 0 ,Lg e n e s :u l 1 7 ,
ul18, ul27, ul32, ul33, ul35, ul37 and ul41. Peaking of
the us3 gene expression at 4 h can be explained by the
important role of US3 protein kinase in blocking the
apoptotic pathway of the compromised cell in the E
phase of infection [61]. Our kinetic classifications
accorded more strongly with those published on the
H S Vt h a nw i t ht h o s eo nt h eP R V .T h er e a s o nm a yb et h a t
the expression profiling of PRV genes was performed by
others with low resolution techniques. Our data allow
the following conclusions: (1) there is no sharp
BMC Genomics 2009, 10:491 http://www.biomedcentral.com/1471-2164/10/491
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Name Transcription Kinetics Function(s)
b References
Wagner
37 Wagner
38 Roizman
39 Roizman
40 Mettenleiter
41 Mettenleiter
41 Our
data
a
orf-1 --- - - N D L u n k n o w n
ul54 (*ICP27) IE IE IE IE IE E E transcription regulation [40]
ul53 (gK) L EL L L L (EL) 3 h pi E/L viral egress [40]
ul52 E E E E E ( E )2hp i E DNA replication [40]
ul51 L EL L L L E L viral egress/oralgen unknown [40]
ul50 (*dUTPase) E E E E E (EL) 3 h pi E dUTPase, viral replication [27]
ul49.5 (gN) L L L2 L2 L L L virion entry [39]
ul49 (*VP22) E? E L L E (EL) 4 h pi L virion formation, tegumentation [27]
ul48 (*VP16, IE-TIF) ? EL L L L (L) 8 h pi L gene regulation, viral egress [41]
ul47 (*VP13/14) E EL L2 L2 L L L secondary envelopment [41]
ul46 (*VP11/12) E EL L L L E E/L unknown function, tegument protein [41]
ul27 (gB) E EL L1 L1 E ND L cell-cell spread, virus entry [27]
ul28 (*ICP18.5) E EL L L E E E DNA cleavage and packaging [27]
ul29 (*ICP8) E E E E ND ND E DNA replication [27]
ul30 EEE L E N D E DNA replication [27]
ul31 L E L L 2 L 2 L ( L )6hp i L n u c l e a re g r e s s [ 4 2 ]
ul32 LE LL 2L 2 L N D L DNA packaging [2]
ul33 LE L ? L L N D L encapsidation of viral DNA [43]
ul34 L L ? L N D ( E L )3hp i L n u c l e a re g r e s s [ 1 4 ]
ul35 (*VP26) L L L2 L2 L ND L capsid protein [44]
ul36 (*VP1/2) ? E L L 2 L 2 L ( E L )3 - 9hp i L t e g u m e n t a t i o na n de g r e s s [ 4 5 ]
ul37 L E L L L (E) 2 h pi L secondary envelopement, egress [45]
ul38 (*VP19c) L L L 2 L 2 L ( E )2hp i L capsid protein [46]
ul39 (RR1) E E E E E (E) E/L E/L nucleotide synthesis [46]
ul40 (RR2) E E E E E E E nucleotide synthesis [47]
ul41 (VHS) L EL L L L ND L RNase, gene regulation [48]
ul42 L E E E E L L DNA replication [47]
ul43 L EL ? L E E E/L unknown [49]
ul44 (gC) L L L2 L2 L L L viral entry, virion attachment [50]
ul26 E L L L L L L scaffold protease [52]
ul25 L EL L L L L L capsid protein [51]
ul24 (*VP24) LLL L L LL unknown [52]
ul23 (TK) E E E E E E E nucleotide synthesis [47]
ul22 (gH) L L L2 L2 L L L viral entry, cell-cell spread [47]
ul21 L E ? L L L E capsid maturation [47]
ul20 L EL L L L ND E/L capsid transport [2]
ul19 (*VP5) L E L L 1 L 1 L ( L )1 6hp i L capsid protein [53]
ul18 (*VP23) LE LL L L N D L capsid protein [27]
ul17 LE LL L L N D L DNA cleavage and encapsidation [2]
ul16 ?E L? L L N D L unknown, interacts with UL11 [27]
ul15 L EL L L L ND E/L DNA cleavage and encapsidation [27]
ul14 LE L ? L L L E / L DNA cleavage and packaging [47]
ul13 (*VP18.8) L EL L L L (E) EL E protein phosphorylation [47]
ul12 (*AN) E E E E E (E) EL E alkaline nuclease [47]
ul11 L EL L(?) L L L E secondary envelopement [47]
ul10 (gM) L E L L L E L egress, secondary envelopement [54]
ul9 (*OBP) EE L ( ? )E E EE ori depentent DNA synthesis [54]
ul8 (*OBPC) E E E E E (E/L) 3-5 h pi E DNA replication [54]
ul7 ?E E ? ND L (E/L) dE E/L unknown [54]
ul6 LE ?N D L ( E / L ) d E L capsid protein, portal protein [54]
ul5 E E E E E ( L )6hp i L DNA replication [55]
ul4 E E ? L L ( L )6hp i E / L unknown [55]
ul3.5 - - - - - E/L L replication, cell-to-cell spread [55]
ul3 L L L2 L2 L E/L L unknown [55]
ul2 (*UNG) EEE L E E / L L DNA repair [55]
ul1 (gL) E EL1 L L L E/L L viral entry, cell-to-cell spread [55]
ep0 (*ICP0) IE IE IE IE E E E gene regulation [10]
llt1 L ND ND ND ND ND L latency [56]
llt2 L ND ND ND ND ND E latency [56]
ie180 (*ICP4) IE IE IE IE IE IE E/L gene regulation [13]
us1 (*RSp40/ICP22) IE IE IE IE IE IE L regulator of gene expression [27]
us3 (PK) E E E E/L E E E nuclear egress [27]
BMC Genomics 2009, 10:491 http://www.biomedcentral.com/1471-2164/10/491
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(page number not for citation purposes)boundary between the E and L genes; (2) classification of
the PRV genes on the basis of the Ri-PAA values yielded
similar results those for the homologous HSV genes. A
noteworthy exception is the us1 gene, which according
to our PAA analysis is expressed in L kinetics; (3) the
ie180 and llt genes cannot be classified on the basis of
the Ri-PAA data alone, because they display unique
expression kinetics; (4) LLT1 and LLT2 respond differ-
ently to CHX and PAA treatment, indicating that these
antisense transcripts are, at least partially, under different
regulation. We assume that the putative antisense
promoter (ASP; [10]) controls the expression of LLT2.
Kinetics of PRV gene expression in untreated cells
Real-time RT-PCR is a high-resolution technique, which
allows a detailed analysis of gene expression dynamics
and a reliable temporal classification of viral mRNAs
without drug treatment. The data from these experiments
are presented in detail in the text [see Additional file 2
and 4]. The us3 PRV gene peaks at 4 h, llt2 at 2 h, while
the other genes reach their maximum at 6 h within the
0-6 h examination period.
0-6 h incubation period
The accurate and reproducible data generated by real-
time PCR allow the analysis of gene expression
throughout the entire time course of infection. In order
to classify genes on the basis of their expression kinetics,
we performed Pearson's correlation analysis for each
gene pair of the PRV, using the net increase (RΔ)i ne a c h
time interval for the comparison [see Additional file 4b].
Genes were clustered into the same group if their
pairwise correlation coefficients were high, ranging
from r ≥ 0.9 to 0.99 depending on the group.
Surprisingly, genes belonging in a particular group very
rarely give similarly high values as any of the genes
belonging in other groups. Albeit Pearson's coefficient
expresses the kinetic properties of a gene in single
numbers, the expression curves of genes belonging in the
same group proved to be very similar (Figures 5, 6, 7, 8,
9, 10, 11, 12, 13, 14, 15). We distinguished 10 gene sets.
Group L1 of PRV genes (each pair shared r ≥ 0.989
values) contains 24 genes, of which 22 were identified as
L and two as E/L genes by our PAA analysis. The only
exception was ul13 which although an L gene in the
HSV, behaved as an E gene in all of our analyses. The
profile curves of the genes clustered on the basis of
Pearson's correlation of pairwise RΔ values, gave very
similar patterns of expression within the groups. In each
period of time, the expression curves can also be
characterized by the formula: RΔ(t+1) -R Δt (Table 2).
For example, group L1 was characterized by hardly any
change in the first 2 h, a moderate rise in mRNA level
between 2 and 4 h, and a sudden increase in mRNA copy
number from 4 to 6 h (0/+/++). Group L2 (r ≥ 0.99)
contains one E/L and 6 L genes. The expression profiles
of these genes are characterized by a continuous
intensive increase from 2 to 6 h (0/+/+). Our PAA
analysis revealed that all of the 6 members of group L3
(r ≥ 0.99) are L genes, except for us1, which is an IE gene
in the HSV. In our system, therefore, most of the data
(except the relatively high R2h for us1) ,s u g g e s tt h a ti ti s
an L gene. This group is characterized by the expression
profile 0+/0-/+++. Group E1 (r ≥ 0.91; with 5 members)
and group E2 (r ≥ 0.901, with 5 members) comprise E
genes, except for ul53,w h i c hi sa nLg e n ei nt h eH S V .
However, this gene is characterized as an E gene in the
PRV [39], which was confirmed by our PAA analysis.
These genes are characterized by the expression profile:
0+/+/-. Group E3 (r = 0,964, 2 members: ul11 and ul9),
expression profile: +/+/0+; Group E4 (r = 0.996, 2
members: ul12 and us4), profile: 0/+/0. Group M1 (r ≥
0.933) is composed of 8 members, shown by our PAA
analysis to exhibit either E or L kinetics. The expression
profiles of these genes are very similar (0/+/++), which
draws attention to the fact that PAA analysis alone is not
sufficient for the grouping of genes with a similar
expression profile. The 3 members of group M2 exhibit a
very high correlation (r ≥ 0.998) and similar expression
profiles (0/++/+). Group LLT (r > 0.946) contains 2 llt genes
that have an unusual expression profile (++/--/+++). The
following 4 genes cannot be clustered on the basis of
Pearson's coefficients: ie180 (--/++/++), ul30 (--/--/++),
ul34 (+/+/+) and us3 (+/++/---), which are likewise
unusual Indeed, these genes have peculiar expression
profiles (Figure 16). The expression profile can also be
Table 1: Function and kinetic grouping of PRV genes (Continued)
us4 (gG) E E L L E/L E E/L unknown [57]
us6 (gD) L E L1 E/L E/L ND E/L entry [27]
us7 (gI) E E L L L (L) 6 h pi E/L cell-to-cell spread [27]
us8 (gE) E E L2 L2 L E E/L cell-to-cell spread [58]
us9 (*11K) E E ? L L L E/L anterograde spreed of virus [58]
us2 (*28K) E E ? L L ( L )5hp i E / L unknown [27]
This Table demonstrates the function and kinetic classification of PRV genes in comparison with available data on HSV and PRV genes.
a PRV genes were classified on the bases of the ratio of the PAA-treated and untreated samples, at 6 h pi.
b Gene functions in italics rely on studies of the HSV-1 homologs.
BMC Genomics 2009, 10:491 http://www.biomedcentral.com/1471-2164/10/491
Page 7 of 22
(page number not for citation purposes)Figure 4
Clustering of genes on the basis of the effects of PAA on gene expression. Horizontal bars show the PRV genes
ranked on the basis of Ri-PAA values in an increasing sequence. Early and late gene clusters were separated by a set of genes
labeled as E/L using arbitrarily given threshold values.
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(page number not for citation purposes)visualized by heatmap presentation, using the expression
data generated with the RΔtvalues (Figure 17).
Co-regulated gene clusters
We utilized our data to analyze whether the expression
properties of PRV genes localized in adjacent genomic
loci display similarities.
PAA analysis
Figure 18 shows an intriguing relationship between
genes categorized on the basis of the data of the PAA
experiments. Nested 3' co-terminal genes were found to
belong in the same kinetic classes, indicating the
existence of shared regulatory mechanisms of gene
expression. An exception is the late ul27 gene, which
forms a cluster overlapping in parallel with the ul28 and
ul29 genes expressed with E kinetics. Of the 11 divergent
pairs, 6 genes were found to belong in the same and 5 in
different kinetic classes. A further special feature of the
PRV genome is that the convergent genes mostly belong
in different kinetic classes (Figure 18). The potential role
of such organization of the herpesvirus genome is
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Figure 6
Grouping and plotting of PRV genes using their RΔ
values. Pearson's correlation analysis was performed to
group the PRV genes into clusters on the basis of similar
expression dynamics (using pairwise RΔ values) over the four
time intervals.
Time (h)
01234567
R
(
t
+
1
)
-
R
t
0,0
0,1
0,2
0,3
0,4
0,5
0,6
ul11
ul9
Group E3
Figure 7
Grouping and plotting of PRV genes using their RΔ
values. Pearson's correlation analysis was performed to
group the PRV genes into clusters on the basis of similar
expression dynamics (using pairwise RΔ values) over the four
time intervals.
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Figure 8
Grouping and plotting of PRV genes using their RΔ
values. Pearson's correlation analysis was performed to
group the PRV genes into clusters on the basis of similar
expression dynamics (using pairwise RΔ values) over the four
time intervals.
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Figure 5
Grouping and plotting of PRV genes using their RΔ
values. Pearson's correlation analysis was performed to
group the PRV genes into clusters on the basis of similar
expression dynamics (using pairwise RΔ values) over the four
time intervals.
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(page number not for citation purposes)discussed later. It may be noted that most US genes
belong in the E/L kinetic class accounting for 37.5% of
this group.
Pearson's correlation
Analysis of the gene clusters generated by using Pearson's
correlation coefficients revealed that genes within the
same clusters are often located in neighboring genomic
positions. Group L1 is composed of 24 members. The
adjacent ul1, ul2, ul3, ul5 and ul6 g e n e sa r em e m b e r so f
this group. The high pairwise correlation coefficients and
the similar profile curves of the RΔ values of these genes
cannot be explained by the nested co-localization alone,
because ul5 and ul6 are divergent genes and do not
overlap with ul1, ul2 and ul3.T h eul44 gene is convergent
with ul24 and ul26;a n dul22 is divergent with ul20.
Moreover, ul27 is convergent with ul47 and ul48.I t
should e borne in mind that ul26 and ul27,a na d j a c e n t
gene pair in the HSV, are relocalized into a remote
position in the PRV, due to a large inversion, but retain
their expression properties. This is also true for ul44,
ul47,a n dul48 (there is no ul45 gene in the PRV). Several
genes (us2, us6, us8 and us9) in the US region of the PRV
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Figure 9
Grouping and plotting of PRV genes using their RΔ
values. Pearson's correlation analysis was performed to
group the PRV genes into clusters on the basis of similar
expression dynamics (using pairwise RΔ values) over the four
time intervals.
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Figure 10
Grouping and plotting of PRV genes using their RΔ
values. Pearson's correlation analysis was performed to
group the PRV genes into clusters on the basis of similar
expression dynamics (using pairwise RΔ values) over the four
time intervals.
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Figure 11
Grouping and plotting of PRV genes using their RΔ
values. Pearson's correlation analysis was performed to
group the PRV genes into clusters on the basis of similar
expression dynamics (using pairwise RΔ values) over the four
time intervals.
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Figure 12
Grouping and plotting of PRV genes using their RΔ
values. Pearson's correlation analysis was performed to
group the PRV genes into clusters on the basis of similar
expression dynamics (using pairwise RΔ values) over the four
time intervals.
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(page number not for citation purposes)genome belong in this group, too. The ul17 and ul19
genes, which are oriented parallelly, but non-overlap-
ping, likewise belong in group L1. The ul34 and ul35
genes are in a divergent position with ul37.G r o u pL 2i s
composed of 7 members. The ul32 and ul33 genes are
divergently oriented, while ul4 and ul3.5 are convergent
genes. Group L3 is a small group with 6 members. The
ul36 and ul38 genes are arranged in a divergent
orientation. Group E2: Two of the 4 members of this
group, ul28 and ul29, are overlapping genes. Group E3:
Two (ul11 and ul12) of the 4 members of this group are
divergently oriented with the third member, ul9. Group
M1: ul7 and ul8 are a convergent gene pair. The ul49.5
and ul51 are L genes oriented in parallel and separated
by the divergent early ul50 gene. Furthermore, ul15 and
ul17 are a convergent adjacent gene pair. Genes with
similar expression profiles appear to be under a common
regulation, which cannot be explained solely by the
nested localization (these genes also have common
promoters) of genes. Group LLT: the llt1 and llt2
expression patterns show a high degree of similarity.
However, there is noteworthy inverse relationship in the
expression profiles of LLT1 and LLT2 with those of their
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Figure 13
Grouping and plotting of PRV genes using their RΔ
values. Pearson's correlation analysis was performed to
group the PRV genes into clusters on the basis of similar
expression dynamics (using pairwise RΔ values) over the four
time intervals.
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Figure 14
Grouping and plotting of PRV genes using their RΔ
values. Pearson's correlation analysis was performed to
group the PRV genes into clusters on the basis of similar
expression dynamics (using pairwise RΔ values) over the four
time intervals.
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Grouping and plotting of PRV genes using their RΔ
values. Pearson's correlation analysis was performed to
group the PRV genes into clusters on the basis of similar
expression dynamics (using pairwise RΔ values) over the four
time intervals.
Table 2: Grouping PRV genes on the basis of expression curves
group L1 L2 L3 E1 E2 E3 E4 M1 M2 LLT
profile 0/+/+++ 0/+/+ 0/0/+++ 0/+/- 0/++/-- +/+/0+ 0/+/0 0/+/++ 0/++/+ ++/--/+++
gene ie180 ul30 ul34 us3
profile --/++/++ --/--/++ +/+/+ +/++/---
Gene expression profiles of PRV gene clusters were characterized by plus and minus signs at various time intervals [Rt(2h-1h)-R (t1h-0h) ;R t(4h-2h)-
R(t2h-1h);R t(6h-4h)-R (41h-2h)]. The numbers of plus or minus signs indicate the relative rate of increase or decrease of transcripts.
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(page number not for citation purposes)complementary partners, EP0 and IE180 mRNAs, respec-
tively (Figure 19).
Discussion
Gene expressions of a-herpesviruses have already been
analyzed by various techniques including Northern-blot
and microarray analysis. Different authors have often
assigned the same genes to different kinetic groups,
which may be explained by the poor resolution of the
applied techniques. Only partial data are available on
the expression of PRV genes. Flori et al. [27] carried out
genome-wide gene expression analysis via a microarray
technique, but this approach did not produce evaluable
data on the kinetic properties of the PRV genes. We
employed a novel qRT2-PCR technique using (1) strand-
specific primers for the RT to obtain a higher yield and to
eliminate the effects of the potential antisense tran-
scripts; and (2) the average maximal E
Ct values as the
controls for the calculation of relative expression ratios
(Rs). Other approaches, such as the models of Pfaffl's
[62] and Souazé et al., [63], and the ΔCt and ΔΔCt
models [64] are simpler than the model we used;
however, they all neglect the variation in the amplifica-
tion efficiencies between cDNA samples, which was
present in our system. Traditionally, herpesvirus genes
are grouped into kinetic classes on the basis of gene
expression inhibitory effects of protein and DNA
synthesis-blocking reagents. The IE genes should not be
significantly inhibited by any of the above substances,
the E genes are inhibited only by DNA synthesis
blockers, and the expression of the L genes is substan-
tially inhibited by both protein and DNA synthesis
blockade. We grouped the PRV genes into IE, E, E/L and
L categories on the basis of the results of CHX and PAA
treatment (Table 1), [see Additional file 3]. Our findings
conformed well with those published for the HSV genes.
The expression of the ie180 gene is enhanced by CHX
treatment. The explanation of this phenomenon lies in
the fact that the ie180 protein normally inhibits its own
expression a short time after the onset of virus infection,
a feature which is absent in CHX-treated cells due to
novel protein synthesis being blocked by the drug. The
other PRV genes were inhibited to a significant extent by
CHX at every examined time point. Consequently, ie180
is the only IE gene of the PRV. The ep0 and ul54 genes (IE
genes in the HSV) were shown to be E genes by others
[[10] and [11]], and this was confirmed by our analyses.
Interestingly, us1, which is an IE gene in the HSV,
appeared to be an L gene in most of our analyses: its
expression was significantly inhibited by PAA; it afforded
a low amount of mRNAs at 1 h pi, and a high rate of
increase of transcript level at 4-6 h pi, all of these being L
characteristics. Furthermore, together with a set of L
genes, us1 belongs in group L2 according to the
clustering of the genes on the basis of pairwise Pearson
correlation coefficients. The moderately high relative
amount of us1 t r a n s c r i p t sa t2hp ii st h eo n l yE - l i k e
characteristic of this gene. However, us1 displays a high
Ct value, suggesting a low absolute amount of transcripts
at 2 h pi. We may mention here that the Ct value of a
transcript is dependent on the primer efficiency; these
data therefore cannot be reliably used to the estimate the
absolute transcript amount. If the us1 gene has an
important function early in the lytic cycle of the virus, it
might fulfill this without de novo synthesis by being
released upon infection from the tegument layer of the
virus where it might be incorporated. Our data do not
demonstrate a clear-cut demarcation line between the
groups of E and L genes, suggesting that the categoriza-
tion of herpesvirus genes on the basis of the require-
ments for DNA replication might be arbitrary. The
kinetic types of genes identified by our PAA analysis
resemble homologous HSV genes more than the
published PRV genes, which can be explained by the
semiquantitative methods used for the kinetic analysis of
the PRV genes. The present study revealed that temporal
classification of herpesvirus genes is also possible
through study of the gene expression of untreated cells
in consequence of the high sensitivity of the real-time
RT-PCR technique. As a further interesting point, we
detected mRNAs by qRT2-PCR in all but 3 PRV genes as
early as 1 h pi [see Additional file 4]. This observation
indicates that PRV genes are either leaky or subject to
regulatory mechanisms which have not yet been eluci-
dated. We found that E genes are generally expressed in a
higher proportion than L genes at 1, 2 and 4 h, as
indicated by their higher R values at these time points
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Expression kinetics of some selected genes via their R
values. This Figure shows the expression curves involving
the R values of the only IE (ie180) gene, a typical E gene
(ul40)a n dat y p i c a lL( ul24) gene, two genes with irregular
expression profiles: us1 (local minimum at 4 h pi) and us3
(maximal expression at 4 h pi), and llt1 and llt2.
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(page number not for citation purposes)Figure 17
Clusters of PRV RΔ values identified by the hierarchical clustering method. The dendogram depicts the whole-
genome profiling of protein-coding PRV genes, following de novo infection of PK-15 cells. Green indicates negative RΔ values,
white low RΔ values, gray intermediate RΔ values, and black the highest level of increase in viral mRNA detected between two
time points.
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PRV genome. PRV genes are represented as arrows, which indicate their relative lengths, orientations and kinetic classes
determined by PAA analysis. Red indicates IE kinetics, black E kinetics, gray E/L kinetics, and white L kinetics.
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(page number not for citation purposes)[see Additional file 4a]. The E gene products proved to
display a higher net increase (RΔ) than the L genes within
the 0-1 h, 1-2 h and 2-4 h pi periods. However, by the
4-6 h pi interval, this trend had definitely reversed, i.e.
the L genes exhibited high R(6h-4h) values (Additional file
4b). Unexpectedly, the ratio of increase (Ra) between 1
and 2 h was higher for a number of L genes than any of
t h eEg e n e s[ s e eA d d i t i o n a lf i l e4 c ] .S i n c et h eR 2h values
of these L genes were lower than those of the E genes, the
high R(2h/1h) value is a result of the very low R1h values
of late genes. Most of the L genes also have higher
R(4h/2h) and R(6h/4h) values than those of E genes, which
is explained by the fact that the E genes reach a relatively
high expression level by 1 h pi. The classification of the
PRV genes through the CHX and PAA analyses led to
results very similar those generated by the analysis of
untreated cells via the following calculation: R(6h-4h)/
R(1h-0h) [see Additional file 5]. The differences between
the results of the two approaches can be explained in
that PAA analysis alone gives only a rough picture of the
gene expression; a detailed kinetic analysis of the viral
gene expression furnishes a more sophisticated picture.
Some genes classified as E or L by PAA analysis display
"irregular" kinetics under untreated conditions. The
ie180 and perhaps us1 genes cannot be classified by
PAA analysis alone. Analysis of the transcription kinetics
of overlapping transcript sets is an important issue. It is
not known whether downstream genes on polycistronic
mRNAs are translated, and if so, to what extent. This
makes interpretation of the mRNA expression data
difficult because the mRNA levels cannot be correlated
with the amounts of the corresponding proteins, which
are the workhorse molecules in regulating cellular
physiology. In principle, a downstream gene is translated
if it is transcribed from its own promoter. Theoretically,
downstream genes could also be translated from a
polycistronic RNA if alternative splicing removed
upstream gene(s) from the pre-mRNA, or if potential
IRES-like sequences helped recruit ribosomes, thereby
initiating a cap-independent translation from the down-
stream gene (we have found no data in the literature
concerning these possibilities). Thus, analysis of the
downstream genes without discriminating between
transcription from their own promoters or by read-
through from upstream genes might result in a false
categorization. The PRV genes were also classified by
analysis of the gene expression throughout the entire
examination period by using Pearson's correlation
analysis. Genes with similar expression profiles (high
pairwise r values) were placed in the same group. Genes
in the same kinetic class (identified by PAA analysis) are
generally situated in the same group generated by the use
of Person's correlation. Moreover, members of a parti-
cular group (with high r values) rarely display high
correlation coefficients with genes belonging in different
groups. The PRV genes conformed well to 10 patterns of
expression. Only 4 viral genes (ie180, ul30,u l 3 4 and us3)
did not fit into any of the 10 groups. We found an
inverse expression profile of the sense/antisense partners
in the ep0-llt1 and ie180-llt2 genes (Figure 19). Combi-
nation of the untreated data with the results of the CHX
and PAA analyses revealed an interesting relationship for
coordinated regulation of sense/antisense partners. The
CHX analysis suggested that IE180 protein facilitates LAP
(latency-associated transcript promoter) activity, and
inhibits ASP (putative antisense promoter activity). The
PAA treatment resulted in a significantly elevated
antisense transcript level at 3 of the 4 time points in
LLTs, which indicates the existence of another regulatory
level besides IE180 protein action. We assume that
transcription from one DNA strand negatively influences
the expression of transcripts from the complementary
DNA strand. The interaction can occur at the level of
transcription (RNA polymerase moving in one direction
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Figure 19
Inverse expression profiles of sense/antisense
transcripts. The expression curves of RΔ reveal show an
inverse relationship between the mRNAs of genes and their
antisense transcripts: ep0/llt1 and ie180/llt2.
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(page number not for citation purposes)along one of the DNA strands inhibits RNA polymerase
moving in another direction) and/or translation by
forming double-stranded RNAs by the sense and anti-
s e n s et r a n s c r i p t s .A sa ne x a m p l e ,P A Ah a san e g a t i v e
effect on the transcription of ie180 (the level of IE180
mRNA is reduced to a quarter) at 4 h pi, which results in
a lower rate of transcription from ie180 (thereby
facilitating the expression of LLT2); and a lower amount
of inhibitory IE180 proteins, which also facilitates LLT2
expression. Overall, the LLT2 level increases 39.4-fold
relative to the untreated conditions. Furthermore, genes
with the same kinetic properties exhibit a distinctive
distribution pattern along the PRV genome. Nested
genes appear to belong in the same kinetic group.
Additionally, convergent genes and gene clusters in most
(3 out of 11) cases belong to different kinetic classes. It
should be remembered that the PAA-based approach
and the time intervals applied for kinetic analysis
produce only a coarse resolution of gene expression. It
is possible that convergent genes allocated to the same
kinetic classes might display different expression profiles
on a finer scale. The above genome organization
principles may point to the existence of as yet unknown
regulatory mechanisms. It may be speculated whether a
read-through of transcription across convergent genes is
the basis of this regulation. Moreover, groups formed in
terms of high Pearson's correlation coefficients contain
many genes localized at adjacent loci on the PRV
genome. Most genes with high correlation coefficients
are not nested genes. This means that the similarity of
their expression profiles cannot be explained by the
control of a common promoter. Further, several genes in
the same group are separated by genes that display
different kinetic profiles. These results suggest the
existence of a genetic mechanism that synchronizes
gene expression on a higher-order (chromatin?) scale.
Conclusion
Although the relative amounts of the transcripts between
genes cannot be compared because primer efficiencies
may vary both in RT and in PCR, our method allows a
comparison of genes on the basis of their expression
dynamics. We detected the expression of almost all genes
from the earliest time point (1 h), Further, we have
found that a sharp boundary cannot be drawn a between
the groups of E and L genes in terms of expression
profiles. We have also found that the PRV has only a
single IE gene (the ie180 gene) and that the us1 gene is
expressed in L kinetics. Our kinetic studies revealed that
PAA analysis alone is not sufficient for the classification
of genes on the basis of their expression profiles. The
analysis of gene expression throughout the 6 h examina-
tion period demonstrated that these genes can be
subdivided into further clusters, and that genes showing
significant differences in response to PAA treatment can
have very similar expression characteristics in untreated
conditions. In our analysis, nested genes displayed the
same expression profiles, whereas convergent genes
mostly exhibited different kinetic properties. It should
be noted that a finer resolution of the gene expression
might expose slight differences in the expressions of
nested genes. Approximately half of the divergent genes
belong in the same class, and the other half of them in
different kinetic classes. The new calculation technique
that we have developed is also applicable to evaluate the
loss-of-function phenotypes of mutant herpesviruses
viruses and, in principle, for the analysis of gene
expression in every temporally changing genetic system.
Methods
Cells, viruses and infection conditions
Monolayer cultures of immortalized porcine kidney 15
(PK-15) cells were maintained at 37°C in an atmosphere
of 95% air, 5% CO2 in Dulbecco's modified Eagle
medium (DMEM) supplemented with 5% fetal bovine
serum (Gibco) and 80 μg gentamicin per ml. Strain
Kaplan of pseudorabies virus (PRV-Ka) was used for gene
expression analysis. The virus stock was prepared by
infecting PK-15 cells with 10 plaque forming units (pfu)/
cell PRV-Ka followed by incubation of the cells until a
complete cytopathic effect was observed. For the analysis
of the PRV transcriptome, rapidly-growing semi-conflu-
ent PK-15 cells were infected with a low multiplicity of
infection (MOI; 0.1 pfu/cell) of the virus, and incubated
for 1 h, after which the virus suspension was removed
and the cells were washed with phosphate-buffered
saline (PBS). Subsequently, new culture medium was
added to the cells, which were further cultivated for 0, 1,
2, 4 or 6 h. Cells were incubated in the presence or
absence of 100 μg/ml cycloheximide (CHX), a transla-
tion inhibitor, or 400 μg/ml phosphonoacetic acid
(PAA), an inhibitor of DNA synthesis (both purchased
from Sigma-Aldrich) 1 h prior to virus infection. Mock-
infected cells, treated in the same way as infected cells,
were used as controls.
Preparation of viral DNA
Viral DNA was used to test the efficiency and specificity
of the primers applied in real-time PCR. The viral DNA
was purified as follows. Monolayers of PK-15 cells were
infected with the PRV at an MOI of 10, and cultivated at
37°C until a complete cytopathic effect was observed.
Subsequently, culture medium was collected without
disrupting the cells and clarified by centrifugation at
4,000 rpm for 10 min using a Sorvall GS-3 rotor. Next,
the virus in the supernatant fluids was sedimented on a
30% sucrose cushion by ultracentrifugation at 24,000
rpm for 1 h using a Sorvall AH-628 rotor. The
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(page number not for citation purposes)sedimented virus was resuspended in sodium Tris-EDTA
buffer. After the addition of proteinase-K (l00 μg/ml
final concentration) and sodium dodecyl sulfate (SDS;
0.5% final concentration), the lysate was incubated at
37°C for 1 h, which was followed by phenol-chloroform
extraction and dialysis.
Primers
Primers were designed through use of the Primer Express
(Applied Biosystems) and FastPCR Professional (Primer
Digital Ltd.) oligonucleotide design software according
to the given guidelines. Primer pairs were designed from
t h e3 ' - e n dr e g i o n so fO R F sf o re a c hg e n e( T a b l e3 ) .T h e
ul26 and ul26.5,a n dorf1 and orf1.2 genes contain
overlapping ORFs; and we therefore, did not employ
distinct primers for them. Primer specificity was verified
by BLAST searches of the GenBank database (National
Center for Biotechnology Information (NCBI) website
http://www.ncbi.nlm.nih.gov/BLAST/. All primers were
purchased from Bio Basic Inc. (Mississauga, Ontario,
Canada).
Polymerase chain reaction
A conventional PCR technique was used to check on the
potential DNA contamination and the quality and
specificity of the primers. The PCR reaction was carried
out by standard methods on a Veriti™ 96-Well Thermal
Cycler (Applied Biosystems) with the following para-
meters: 1 cycle of 94°C for 4 min; 30 cycles of 94°C for 1
min, 60°C for 1 min and 72°C for 2 min; and 1 cycle of
72°C for 7 min. The PCR reaction was carried out by
using the GC Rich PCR System (Roche). The complete
D N As e q u e n c eo ft h eP R Vi sac o m p o s i t eo f6d i f f e r e n t
strains [65], but the variation between them is very small
(around 1%). Most of the sequence data (86.7%) have
b e e nd e r i v e df r o ms t r a i nK a p l a n( P R V - K a ) ,w h i c hw e
used in our experiments. To circumvent the problem of
genetic background differences, we tested 2 or more
primers for RT and PCR reactions for non-Ka sequences
and selected those that performed best; alternatively, we
sequenced the particular DNA region and designed new
primers on the basis of the sequence data. For each gene,
we designed and tested various primers, and selected
those, which did not produce primer dimers or other
nonspecific products. For those genes where we could
not eliminate the problem of primer dimer formation, in
every cycle we applied an extra extension step with an
elevated temperature (below the Tm of the specific
product and well above the Tm of the primer dimers) for
the detection.
RNA preparation
PK-15 cells (5 × 10
6 cells per flask) were washed in PBS
and harvested for RNA isolation at 0, 1, 2, 4 and 6 h pi.
For quantitative RT2-PCR, total RNA was extracted from
the cells with the NucleoSpin RNA II Kit (Macherey-
Nagel GmbH and Co. KG) according to the manufac-
turer's instructions. Briefly, cells were collected by low-
speed centrifugation, lysed in a buffer containing the
chaotropic ions needed for the inactivation of RNases
and providing the conditions for binding of nucleic acids
to a silica membrane. Next, contaminating DNA was
removed with RNase-free rDNase solution (included in
the NucleoSpin RNA II Kit). Subsequently, the RNA
solution was treated with Turbo DNase (Ambion Inc.) to
remove potential residual DNA contamination. Finally,
RNA was eluted in RNase-Free Water (supplied with the
kit) in a total volume of 60 μl. RNA concentration was
determined in triplicate by spectrophotometric analysis
of the absorbance at 260 nm with a BioPhotometer Plus
(Eppendorf). The RNA solution was stored at -80°C
until use.
Quantitative real-time RT-PCR
A two-step quantitative real-time RT-PCR was carried out
for the transcriptional analysis. For each gene, a
minimum of 3 independent replicates (separate infec-
tions) were performed.
Reverse transcription (RT) Total RNA isolated from
infected cell cultures subje c t e dt od r u gt r e a t m e n t( C H X
or PAA) was reverse-transcribed into cDNA for PCR
analysis. RTs were performed in 5 μlo fs o l u t i o n
containing 0.07 μg of total RNA, 2 pmol of the gene-
specific primer, 0.25 μlo fd N T Pm i x( 1 0μMf i n a l
concentration), 1 μl of 5× First-Strand Buffer, 0.25 μl( 5 0
units/μl) of SuperScript III Reverse Transcriptase (Invi-
trogen) and 1 U of RNAsin (Applied Biosystems Inc.)
and the mixture was incubated at 55°C for 60 min. The
reaction was stopped by raising the temperature to 70°C
for 15 min. No-RT control reactions (RT reactions
without Superscript III enzyme) were run to test the
potential viral DNA contamination by conventional
PCR. RNA samples with no detectable DNA contamina-
tion were used for quantitative RT-PCR reactions. First-
strand cDNAs were diluted 10-fold with DEPC-treated
water (Ambion Inc.), then subjected to real-time PCR
analysis.
Real-time quantitative PCR experiments were performed
with a Rotor-Gene 6000 cycler (Corbett Life Science). All
reactions were carried out in 20-μl reaction mixtures
containing 7 μl of cDNAs, 10 μl of ABsolute QPCR SYBR
Green Mix (Thermo Fisher Scientific), 1.5 μlo ff o r w a r d
and 1.5 μlo fr e v e r s ep r i m e r s( 1 0μMe a c h ) .T h er u n n i n g
conditions were as follows: (1) 15 min at 95°C,
followed by 30 cycles of 94°C for 25 sec (denaturation),
60°C for 25 s (annealing), and 72°C for 6 s (extension).
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a
Name
b Forward primer sequence (5'-3')
c Reverse primer sequence (5'-3')
d Primer
coordinates
e
Size of
amplicon
(bp)
f
orf1 GCC TCG TGT TTC TGA TCC TGC TC AAC ACG ACA GAC TCC CGG AGC A 2204-2252 49
ul54 TGC AGC TAC ACC CTC GTC C TCA AAA CAG GTG GTT GCA GTA AA 2730-2795 66
ul53 CCA AGG CGC TGT ACC TCT G TGT GCC GCT CAT AGT GCA G 3912-3977 66
ul52 CGC GCA ACT TTC ACT TCC ACG CA TGC GCT CGA AGA AGC TCT CGT A 5325-5376 93
ul51 GCT CAT GCA CCT GTA CCT CTC G ACG TCG GAC ATC ACC ACG TTG C 7989-8096 108
ul50 CTT CTT CGA GGT CTT TGC GC ATG TCG TAT CCG GCG TCC T 8921-8971 51
ul49.5 TGA CAT TTT ATA TCT GCC TCC TGG TGC AGC ATC CGG GTG C 9447-9525 79
ul49 CAT CAC CGT GTG CGA G CTT TTC CCT TCC GCC CG 10247-10329 83
ul48 AGG TGC GGA TCA AGA TGG AG CAG TAC GTG TGG TCG CGG T 11305-11359 55
ul47 GAG CTC ATG GAC GCG CTC CTG GCG CAT GAC GGC GTC 13684-13767 84
ul46 TGC TGT GGT CGA CGT TCG TCT GGG CCT TGT GCT TGA A 14435-14494 60
ul27 ACT ACG AGG ACT ACA ACT ACG TGC G GTC ACC CGC GTG CTG ATC 17512-17575 64
ul28 GCG CTC TAC TTT GCG GTG GAG AA GAA CTC GCT GAC GCA CCA ATC G 19781-19879 117
ul29 CTG ATC CTG CGC TAC TGC G ACT GCA TCG TGA TCC CCG 22609-22675 67
ul30 TCA TCA CGA AGA AGA AGT ACA TCG G CCT TCA TGA GCA TCT TGC CG 27959-28015 57
ul31 GTG GCA GAC CAT GTT CGT GT GGT CTC CCG TCT CCC TTC TT 28809-28859 51
ul32 TGC TCA GCT ACT CGG AGA ACA AC CAC GGG CTC GAT GCA GTC 29841-29893 53
ul33 CGC GCG AGC TGG AAG T TGC GTG TGG GCC AGA TAA 31031-31094 64
ul34 AGC ACA ACA ACG TGA TCC TGG GAG AGG CTC ATG CCG GTG 31696-31747 52
ul35 ATC ATG TCC TTC GAC CCG AAC GAG CGT CTG CGC GGT GA 32238-32288 51
ul36 CGT CGG TGG GTA TTA GAG ACC A GAA CAA GAG CCA TGG ATT TTC G 34451-34501 51
ul37 CTA CGA CAT GGA CTT TGT GCA GGA AGT TGG TGT GCT GCG CCA CGT A 44556-44611 56
ul38 CAC CCG GAA CTC GTG CAT GTA CAG AAG AAA CAC TCC TCC CAC G 46118-46273 156
ul39 GCT GGC CAA GTT CAA GAC G CGC ACA TGT CGA TGA GCA G 48701-48759 59
ul40 GGA CTT TCC CAT GGC GC GCT CGA AAA AGT TGG TGT GCT T 49802-49854 53
ul41 TGA AGA ACG AGA CGC GGG TGT GTT TCC AAA ACA GGC CC 50475-50525 51
ul42 GCT CCC CGA GCG TCG CAT GAT GCA GTA GTC GTT GAA CTC 52118-52173 56
ul43 CTG GTG CAG GCG TAC GTG A GGA TTT AAT GCT AGT GGC GCA 53904-53954 51
ul44 TCG TGA GCA GCA TGA TCG T GTC GCC ATG ATG ACC AGC 55368-55437 70
ul26 TTC TTC CTC GGC GTC GTC AAC TG GTA GTT GCT CAG CAG GTA CAG CA 56962-57087 126
ul25 GGC AGT TTG GCG TCT CCA G CCA GGC AGA GAA AGT ACA GGA GG 57336-57386 51
ul24 TGT GCT TCG TCA TCG AGC TC TGG GCG TGT TGA GGT TCC 59249-59305 57
ul23 ATG ACG GTC GTC TTT GAC CGC CAC CGC TGA TGT CCC CGA CGA TGA A 59818-59898 81
ul22 GGC GGC CAT CAC CGT GAG AAT AGC CCT CGG AGG AGA 62574-62647 74
ul21 TCA GCT GTT TCG GGC GC ATT GAG GAC GAT GGA GAT GTT GG 64500-64551 52
ul20 GAG AAC GAC GCG CTG CTG AG CAG GAG GCT CAC CAC GTG 66226-66309 84
ul19 TCT TTG CGG AGA AGG CCA G GCT CTC GGT GCG CGC 69841-69905 65
ul18 TGG TGC TGA ACA TGA TCT TCC GGA TGA GCG ACA GCA GGA T 71443-71502 60
ul17 GGC GTT TTC CTC TTC GAC TAC TAC CAC CCT TAT AAC CTC CCC GC 74663-74713 51
ul16 CTG TGG CGC CAG GCG GAC AA GAT CTT GCG GCG GGG GAG CAT G 75670-75780 111
ul15 CAG AAG CAA AAG ACC CCC G CGA GTT GAA CTG CTT GAC GAA A 72204-72254 51
ul14 CGG ACA AGA AAA ACC CCG AG CCT GTT TGG CCG CCA TAA A 77167-77217 51
ul13 AGC CAC CTG GAC GTC AAG G CCA TGA GGC TAA AGT CCC CG 78083-78173 91
ul12 GCA GAC GGA GAT GCG CTT CCG AGA ACA GGT ACT TGG CG 79394-79449 56
ul11 ATG GGA CAG TGT TGC TGC C TCA AAG TCC TCG AAC GCG T 80084-80178 95
ul10 CAT TTT GTG TTT CTC GCC CTC TTT ACC CGT GCC CTT GCA GG 81390-81443 54
ul9 CAA GTT CAA GCA CCT GTT CGA TGA GGC TGT CGT TGA CGC 83337-83392 56
ul8 CCG CTG ATC CTG CCC TG GAA GAT GGG CTC CAT GTG G 86355-86405 51
ul7 TCC GCG GGT TCG CCT TC AGC GAG AGC ACG CGG TC 87217-87271 55
ul6 CAG GAG CTG ATC CGC TGC TGT TGG AGT ACG AGA CGG ACA C 87687-87765 79
ul5 TGG ACA TGG CCA CCT ACG T ACC GCG CGA TGG TCA T 91530-91592 63
ul4 GAG CGA GAC CGA CCA TGA C TTA TTT CGT AAA ACG AGT AGG CCA 91849-91899 51
ul3.5 CAA CGG AGC ATC AAC GCC TC ATT GAT CGC GGT AGC AAC AGG A 92478-92658 181
ul3 CTG GGC GCA GCA CGT TCC ACG GAC GCG ACC ATA 93502-93552 51
ul2 TTC AGG ACC TGC CCG CAC TTT GGA ACT CAG TCC ACG CTC CAG TCG A 93914-93999 86
ul1 CTG GTC AAC CCC TTT GTC G CGC CTC ATT TAA GGG CTC TC 94928-94987 60
ep0 GGG TGT GAA CTA TAT CGA CAC GTC TCA GAG TCA GAG TGT GCC TCG 96956-97006 51
ie180 CAT CGT GCT GGA CAC CAT CGA G ACG TAG ACG TGG TAG TCC CCC A 103988-104056 69
us1 AGC TCA ACG AGC GCG ACG TCT A CGG AAG CTA AAC TCG GAC GCG A 116466-116602 137
us3 GGG CTT TCC TGA TTT ACA AGA TGT AAG GGC GGC GGA CG 119245-119295 51
us4 ACC TCG ATC TAC ATC TGC GTC G GGC CCT GGT GAT CGC CAT 120764-120850 87
us6 TGG AAC GAC GAG AGC TTC AGG GTA GAA CGG CGT CAG GAA TCG 121690-121749 60
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(page number not for citation purposes)Theabsenceofnonspecificproductsorprimerdimerswas
indicated by observation of a single melting peak in
melting curve analysis. An additional extension and
detection step was applied for those primers that
produced primer dimmers: for 2 s at a temperature just
below the Tm of the specific product and substantially
above the Tm of the primer dimers. With this technique
we could eliminate nonspecific fluorescent signals pro-
duced by primer dimers. Following the PCR reaction,
melting curve analysis was performed to control ampli-
fication specificity (specificity was defined as the produc-
tion of a single peak at the predicted temperature and the
a b s e n c eo fp r i m e rd i m e r s )b ym e a s u r i n gt h ef l u o r e s c e n c e
intensity across the temperature interval from 55°C to
95°C. The 28S ribosomal (r)RNA used as the loading
control (reference gene) was amplified in each run. H2O
was included as a no-template control, and cDNA derived
from the reverse-transcribed RNAs of non-infected cells
was used as a negative mock-infected control. We applied
SYBR Green-based real-time PCR because of the lower
costs and simpler protocol than for TaqMan probe-based
methods for instance. It has recently been demonstrated
that the SYBR-based method of detection is as sensitive
and specific, and has a similar dynamic range to that of
the TaqMan-based technique [66].
Calculation of relative expression ratio (R)
We calculated the R value by using the following
equation:
R =
( max) max
()
:
( max) m Esample
Ctsample
Esample
Ctsample
Eref
Ctref a ax
()
,
Eref
Ctref
where R is the relative expression (quantification) ratio;
E is the efficiency of amplification; Ct is the cycle
threshold value; sample refers to any particular gene at a
given time point; and ref is the 28S rRNA, which was
used as a reference gene and was amplified in each run.
Average Ct values with their standard error (SE) values
and amplification efficiencies with SE are shown in
Additional file 6. This equation is similar to that used by
Soong et al [30]. However, instead of individual values,
we used the average maximal value of E
Ct for each gene
as the control. The relative copy numbers of mRNAs were
calculated by normalizing cDNAs to 28S rRNA using the
Comparative Quantitation module of the Rotor-Gene
6000 software (Version 1.7.28, Corbett Research), which
automatically calculates the real-time PCR efficiency
sample-by-sample. Thresholds were set automatically by
the software.
Analysis and presentation of data
Data were analyzed by the Microsoft Excel program,
using the average and the standard deviance functions.
The inhibitory effect of CHX or PAA was calculated via
the ratio of the drug-treated and untreated R values at 2,
4a n d6hp if o rC H X :R i-CHX = RCHX/RUT,o r4a n d6hp i
for PAA: Ri-PAA = RPAA/RUT. Thus, a low value indicates a
high inhibitory effect and vice versa. The net increase in a
product was calculated by subtracting the R value at time
point t+1 from that at t (RΔ =R (t+1)-Rt), where t = 0, 1, 2,
4 or 6 h and (t+1) = 1, 2, 4 or 6 h. The ratios of adjacent
R values (rate of change; Ra)w e r ec a l c u l a t e dw i t ht h e
following equation: Ra =R ( t+1)/Rt;t=1 ,2 ,4o r6h ;
(t+1) = 2, 4 or 6 h. Pearson's correlation analysis was used
to evaluate qRT2-PCR data, as an alternative method for
the grouping of PRV genes into kinetic classes. Pearson's
correlation coefficient (r) was calculated as follows.
r =
−−
=
∑
−
() ( )
()
Xi XY i Y
i
n
nS xSy
1
1
A correlation is a number between -1 and +1 that
m e a s u r e st h ed e g r e eo fa s s o c i a t i o nb e t w e e nt w ov a r i -
ables [labeled here as X and Y, which are the RΔ values of
two different genes in the same time interval (i)]. X and
Y are the average values, n is the sample number, and SX
and SY are the standard deviances (errors) for X and Y,
respectively. A positive value for the correlation implies a
positive association and a negative value implies a
Table 3: Primer sequences
a (Continued)
us7 CCC GGG AAG ATA GCC ATG AAG AAG ATC AGG AGG ACG ACG 123144-123199 56
us8 CTT CGA CGT CTG GTT CCG C GGT CAC GCC ATA GTT GGG C 125136-125202 67
us9 CAG GAC GAC TCG GAC TGC TA AGG AAC TCG CTG GGC GT 125395-125453 59
us2 CGG CTG GAC ACG GAG TG AGT TCA GGT ACT GGA TCC CGT T 126171-126222 52
28S GGG CCG AAA CGA TCT CAA CC GCC GGG CTT CTT ACC CAT T 54
a This table shows the list of primer pairs used for analysis of PRV gene expression:
b name of the primers
c forward primer sequences
d reverse primer sequences
e Coordinates refer to the PRV genome sequence in strain Ka (NCBI Reference Sequence: NC_006151.1).
f size of the amplified products (amplicons) Underlined sequences were not available from strain Ka, and therefore we sequenced these DNA
segments.
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(page number not for citation purposes)negative or inverse association. Genes were clustered by
using a complete linkage hierarchical clustering method
with a centered correlation similarity metric with Cluster
3.0 software (Stanford University). To view the clustering
results generated by Cluster 3.0, we used Alok Saldanha's
Java TreeView.
Gel electrophoresis
Larger DNA fragments generated by conventional PCR
were run on 1% agarose/TBE gels containing ethidium
bromide and visualized under UV illumination, using
Marker 16 (Lambda DNA/Eco130I; Fermentas) to size
DNA fragments. Smaller DNA fragments generated by
qRT2-PCR were run in a 12% polyacrylamide gel to
ensure that the amplified products had the correct size.
DNA fragments were visualized with ethidium bromide
staining under UV illumination. A GeneRuler™ Low
RangeDNALadder(Fermentas)wasincludedineachrun.
Restriction endonuclease analysis
Ifthereweredoubtsconcerningtheidentityoftheamplified
product,restrictionendonucleaseanalysiswasperformedto
confirm the specificity of the qRT2-PCR products.
Construction of recombinant plasmids
Plasmids containing PRV DNA fragments were constructed
for DNA sequencing analysis, which was performed if
primers designed on the basis of sequence data relating to
non-Ka strains performed badly; or if the identity of
amplicons generated by real-time PCR was uncertain. PRV
DNAs were subcloned by using two methods: PCR
amplification of the particular DNA segment; or subcloning
of the desired DNA region by standard molecular cloning
protocols. Amplified products were subcloned to the pGEM
(Promega) vector in accordance with the manufacturer's
instructions. PRV BamHI fragments to be sequenced were
s u b c l o n e dt ot h ep R L 5 2 5v e c t o r[ 6 7 ] .
DNA sequencing
Subcloned DNA fragments were subjected to DNA sequen-
cing with the ABI Prism™ 3730xl DNA sequencer (AME
BioscienceLtd.).DNAsequenceswereanalyzedbyusingthe
Chromas Lite 2.01 software (Technelysium Pty Ltd).
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Additional file 1
Validation of qRT2-PCR products by restriction endonuclease
analysis. In a few cases, the specificity of PCR products was confirmed
by restriction endonuclease assay. Polyacrylamide gel electrophoresis of
qRT2-PCR products, using primers ul54 (lanes 1 and 2) and us4 (lanes
3 and 4). Amplicon specificity was confirmed by restriction endonuclease
analysis, using SalI (lane 2) and HpaII (lane 4) enzymes. The
GeneRuler™ Low Range DNA Ladder is shown on the left.
Click here for file
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2164-10-491-S1.JPEG]
Additional file 2
Grouping PRV genes according to their expression in untreated cells.
Data of R values of untreated samples.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-10-491-S2.DOC]
Additional file 3
PRV genes ranked on the basis of the effect of PAA on gene
expression. PRV genes were classified on the basis of the inhibitory effect
of PAA (Ri-PAA) on gene expression. Early genes are separated by E/L
genes from late genes. The ie180 gene was classified as IE gene because
its expression was not inhibited by CHX treatment.
a R values of PAA-
treated samples at 4 h post-infection.
b Relative expression ratios of PRV
genes after PAA-treatment at 6 h post-infection.
c Ri-PAA values at 4 h
post-infection.
d PRV genes ranked on their Ri-PAA (6 h pi) values.
e Ri-
PAA values of PRV genes after 6 hours post-infection.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-10-491-S3.PDF]
Additional file 4
PRV genes ranked on the basis of their expression profiles. a R values
Genes were ranked on the basis of their R values at different time points.
a PRV genes ranked on the basis of R values at 1 h pi.
b Relative expression
ratiosofPRVgenes at 1hpi.
cOrder of Rvalues of PRVgenes at 2hpi.
dR
values after 2 hours post infection.
e PRV genes ranked on the basis of R
values at 4 h pi.
f R values at 4 h pi. b. RΔ values Genes were ranked on the
basis of their RΔ values at different time intervals.
a Order of RΔ values of
PRVgenesintheinterval1h-2h.
bRΔvaluesintheintervalbetween1and
2h .
c PRV genes ranked on the basis of their RΔ values in the infection
period from 2 to 4 hours.
d RΔ values in the interval 2 h-4 h.
e PRV genes
ranked on their basis of their RΔ values in the interval 4 h-6 h.
f RΔ values
intheinfectionperiod:4h-6h.c.RavaluesGeneswererankedonthebasis
of their Ra values at different time intervals.
a Order of Ra values of PRV
genes in the interval 1 h-2 h.
b Ra values in the interval between 1 and 2
hours.
c PRV genes ranked on the basis of their Ra values in the infection
period from 2 to 4 hours.
d Ra values in the infection period from 2 to 4
hours.
e PRVgenes ranked ontheir basis oftheirRavalues in theinterval 4
h-6 h.
f Ra values in the interval 4 h-6 h.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-10-491-S4.PDF]
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PRV genes ranked on the basis of their R(6h-4h)/R1h ratios.R (6h-4h)/
R1h values.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-10-491-S5.PDF]
Additional file 6
Average cycle threshold (a) and amplification values (b) with
standard errors.
a Average of cycle threshold (Ct) values based on almost
three separated reactions.
b Standard error of the mean.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-10-491-S6.DOC]
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